Commentary on "Conditional survival of patients with metastatic renal cell carcinoma treated with VEGF-targeted therapy: A population-based study." Harshman LC, Xie W, Bjarnason GA, Knox JJ, MacKenzie M, Wood L, Srinivas S, Vaishampayan UN, Tan MH, Rha SY, Donskov F, Agarwal N, Kollmannsberger C, North S, Rini BI, Heng DY, Choueiri TK, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA: Lancet Oncol 2012;13(9):927-35 (Epub 2012 Aug 8)
- PMID: 23419724
- DOI: 10.1016/j.urolonc.2012.11.006
Commentary on "Conditional survival of patients with metastatic renal cell carcinoma treated with VEGF-targeted therapy: A population-based study." Harshman LC, Xie W, Bjarnason GA, Knox JJ, MacKenzie M, Wood L, Srinivas S, Vaishampayan UN, Tan MH, Rha SY, Donskov F, Agarwal N, Kollmannsberger C, North S, Rini BI, Heng DY, Choueiri TK, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA: Lancet Oncol 2012;13(9):927-35 (Epub 2012 Aug 8)
Comment on
-
Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study.Lancet Oncol. 2012 Sep;13(9):927-35. doi: 10.1016/S1470-2045(12)70285-1. Epub 2012 Aug 8. Lancet Oncol. 2012. PMID: 22877847 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources